MedPath

Effect of Dexmedetomidine on the Characteristics of High Volume/Low Concentration Ropivacaine in a Caudal Block in Pediatrics

Not Applicable
Completed
Conditions
Ambulatory Orchipexy
Interventions
Drug: Caudal ropivacaine + normal saline
Drug: Caudal ropivacaine + dexmedetomidine
Registration Number
NCT02163980
Lead Sponsor
Yonsei University
Brief Summary

The investigators perform this study to evaluate the effects of caudal Dexmedetomidine (DEX) added to high volume/low-concentration of ropivacaine in children undergoing orchiopexy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
80
Inclusion Criteria
  • children undergoing ambulatory orchiopexy,
  • ASA status I
Read More
Exclusion Criteria
  • mental retardation,
  • developmental delay,
  • neurological or psychiatric illness,
  • coagulation disorder,
  • spinal anomalies
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Caudal ropivacaine + normal salineCaudal ropivacaine + normal saline1.5ml kg-1 ropivacaine 0.15% with normal saline (Control group, n=40).
Caudal ropivacaine + dexmedetomidineCaudal ropivacaine + dexmedetomidine1.5ml kg-1 ropivacaine 0.15% with dexmedetomidine 1 μg kg-1 (DEX group, n=40)
Primary Outcome Measures
NameTimeMethod
vital signup to 180 min after surgery

systolic arterial pressure

Secondary Outcome Measures
NameTimeMethod
inhalation anesthetics requirementsup to 180 min after surgery

end-tidal sevoflurane concentration required to maintain hemodynamic changes \< 20% of the preoperative baseline

Trial Locations

Locations (1)

Yonsei Univ. College of Medicine Dep. Of Anesthesiology

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath